Richard S. Finn, Masatoshi Kudo, Philippe Merle, Tim Meyer, ShuKui Qin, Masafumi Ikeda, Ruocai Xu, Julien Edeline, Baek-Yeol Ryoo, Zhenggang Ren, Ann-Lii Cheng, Peter Robert Galle, Shuichi Kaneko, Hiromitsu Kumada, Simcha Pollack, Kalgi Mody, Leonid Dubrovsky, David Eli Adelberg, Josep Llovet. "LEAP-002 long-term follow-up: Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4095